bromodeoxyuridine has been researched along with pentoxifylline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Perras, JP; Ramos, R; Sevin, BU | 1 |
| Hammers, HJ; Saballus, M; Schlenke, P; Sheikzadeh, S | 1 |
3 other study(ies) available for bromodeoxyuridine and pentoxifylline
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Demonstration of an S phase population of cells without DNA synthesis generated by cisplatin and pentoxifylline.
Topics: Bromodeoxyuridine; Cell Cycle; Cisplatin; DNA Replication; DNA, Neoplasm; Drug Synergism; Female; Flow Cytometry; Humans; Ovarian Neoplasms; Pentoxifylline; S Phase; Tumor Cells, Cultured | 1993 |
Introduction of a novel proliferation assay for pharmacological studies allowing the combination of BrdU detection and phenotyping.
Topics: 2-Methoxyestradiol; Antigens, CD19; Bromodeoxyuridine; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Culture Techniques; Cell Division; Cells, Cultured; DNA; Estradiol; G1 Phase; Growth Inhibitors; Humans; Immunophenotyping; Lymphocyte Count; Lymphocyte Subsets; Pentoxifylline; Resting Phase, Cell Cycle; Ultraviolet Rays | 2002 |